CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Progressive ulceration and wound healing complication secondary to bevacizumab in a patient with metastatic breast cancer
DOI 10.1055/s-0028-1088970
Bibliografische Angaben
Nachweis in CareLit
Autor:innenLC Hanker, E Ruckhäberle, C Solbach, M Kaufmann
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Bevacizumab(B) is a monoclonal antibody that inhibits tumor angiogenesis. In the setting of metastatic breast cancer(MBC) the addition of B to paclitaxel(P) results in an improvement of PFS. Side effects include hypertension,proteinuria,gastrointestinal perforation,arterial thrombosis and wound healing complications. A 38-year-old patient with MBC presented with two metastatic cutaneous tumor nodes. She received P80…
Zitieren
Zitierempfehlung
LC Hanker, E Ruckhäberle, C Solbach, M Kaufmann (2008) Progressive ulceration and wound healing complication secondary to bevacizumab in a patient with metastatic breast cancer. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-0028-1088970
Mit CareLit weiterarbeiten